Company Filing History:
Years Active: 2020
Title: Innovations of Xueyun Jiang in Thrombolysis and Antithrombotic Research
Introduction
Xueyun Jiang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that aid in thrombolysis and free radical scavenging. His innovative work has the potential to impact medical treatments significantly.
Latest Patents
Xueyun Jiang holds a patent for a compound with effects of thrombolysis, free radical scavenging, and thrombus-targeting. This invention discloses a novel compound that is a ternary conjugate formed by linking a thrombolytic peptide, a free radical scavenger, and a thrombus-targeting/antithrombotic peptide. The patent also details a preparation method and the use of this compound, which forms a nanospherical structure in a pharmaceutical composition.
Career Highlights
Xueyun Jiang is associated with Shanghai Lumosa Therapeutics Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating effective therapeutic solutions for thrombotic conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Xueyun Jiang collaborates with talented individuals in his field, including Shiqi Peng and Ming Zhao. These partnerships enhance the research and development process, fostering innovation and creativity in their projects.
Conclusion
Xueyun Jiang's contributions to thrombolysis and antithrombotic research exemplify the importance of innovation in the pharmaceutical industry. His patented compound represents a significant advancement in medical science, with the potential to improve treatment options for patients suffering from thrombotic disorders.